Skip to main content
Log in

Social-adaptive and psychological functioning of patients affected by Fabry disease

  • Research Report
  • Published:
Journal of Inherited Metabolic Disease

Summary

Fabry disease (FD) is an X-linked lysosomal storage disorder caused by the deficiency of alpha-galactosidase A. In addition to the debilitating physical symptoms of FD, there are also under-recognized and poorly characterized psychiatric features. As a first step toward characterizing psychiatric features of FD, we administered the Achenbach adult self report questionnaire to 30 FD patients and the Achenbach adult behavior checklist questionnaire to 28 partners/parents/friends of FD patients. Data from at least one of the questionnaires were available on 33 subjects. Analysis focused on social-adaptive functioning in various aspects of daily life and on criteria related to the Diagnostic and statistical manual of mental disorders IV (DSM-IV). Adaptive functioning scale values, which primarily measure social and relationship functioning and occupational success, showed that eight FD patients (six female and two male) had mean adaptive functioning deficits as compared to population norms. Greater rates of depression (P < 0.01), anxiety (P = 0.05), depression and anxiety (P = 0.03), antisocial personality (P < 0.001), attention-deficit/hyperactivity (AD/H; P < 0.01), hyperactivity–impulsivity (P < 0.01), and aggressive behavior (P = 0.03) were associated with poorer adaptive functioning. Decreased social-adaptive functioning in this study was not statistically significantly associated to disease severity, pain, or level of vitality. This study shows for the first time that FD patients, particularly women, are affected by decreased social-adaptive functioning. Comprehensive treatment plans for FD should consider assessments and interventions to evaluate and improve social, occupational, and psychological functioning. Attention to the behavioral aspects of FD could lead to improved treatment outcome and improved quality of life. Individuals affected by Fabry disease exhibited social-adaptive functioning deficits that were significantly correlated with anxiety, depression, antisocial behavior, and AD/H problems in a sampling of our male and female patients aged between 18 years and 59 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ABCL:

adult behavior checklist

AD/H:

attention-deficit/hyperactivity

ASEBA:

Achenbach system of empirically based assessment

ASR:

adult self report

BPI:

brief pain inventory

DSM-IV:

Diagnostic and statistical manual of mental disorders IV

ERT:

Enzyme Replacement Therapy

FD:

Fabry disease

α-gal A:

α-galactosidase A

GL3:

globotriaosylceramide

MSS:

Mainz severity score

SAFD:

social-adaptive functioning deficiency

References

  • Achenbach TM, Rescorla LA (2003) Manual for the ASEBA adult forms and profiles. University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT, www.aseba.org

    Google Scholar 

  • Achenbach TM, Bernstein A, Dumenci L (2005) DSM-oriented scales and statistically based syndromes for ages 18 to 59: Linking taxonomic paradigms to facilitate multitaxonomic approaches. J Pers Assess 84:49–63

    Article  PubMed  Google Scholar 

  • Beck M (2006) The Mainz severity score index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95:43–46

    Article  PubMed  Google Scholar 

  • Berenbaum SA, Bryk KK, Duck SC, Resnick SM (2004) Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 144:741–746

    PubMed  Google Scholar 

  • Brady R, Grabowski GA, Thadhani R (2001) Fabry disease: Review and new perspective. SynerMed Communications 1:1–8

    Google Scholar 

  • Buysse CM, Raat H, Hazelzet JA et al (2007) Long-term psychosocial outcomes in survivors of meningococcal septic shock in childhood, and in their parents. Qual Life Res 16:1567–1576

    Article  PubMed  Google Scholar 

  • Carpenter RE, Loo SK, Yang M, Dang J, Smalley SL (2009) Social functioning difficulties in ADHD: association with PDD risk. Clin Child Psychol Psychiatry 14:329–344

    Article  Google Scholar 

  • Cleeland CS (2002) Pain assessment: the advantages of using pain scales in lysosomal storage diseases. Acta Paediatr Suppl 91:43–47

    Article  PubMed  CAS  Google Scholar 

  • Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138

    PubMed  CAS  Google Scholar 

  • Cole A, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30:943–951

    Article  PubMed  CAS  Google Scholar 

  • Compas BE, Boyer MC, Stanger C et al (2006) Latent variable analysis of coping, anxiety/depression, and somatic symptoms in adolescents with chronic pain. J Consult Clin Psychol 74:1132–1142

    Article  PubMed  Google Scholar 

  • Cubells JF (2007) Beyond irritability and aggressive behavior: does risperidone improve adaptive behavior in autistic spectrum disorders? Curr Psychiatry Rep 9:132–133

    PubMed  Google Scholar 

  • Desnick R, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346

    Article  PubMed  Google Scholar 

  • Gold K, Pastores GM, Botteman MF et al (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317–327

    Article  PubMed  CAS  Google Scholar 

  • Gothelf D, Feinstein C, Thompson T et al (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164:663–669

    Article  PubMed  Google Scholar 

  • Gray D, Parker-Cohen NY, White T, Clark ST, Seiner SHAJ, McMahon WM (2001) A comparison of individual and family psychology of adolescents with chronic fatigue syndrome, rheumatoid arthritis, and mood disorders. J Dev Behav Pediatr 22:234–242

    Article  PubMed  CAS  Google Scholar 

  • Grewal R (1993) Psychiatric disorders in patients with Fabry disease. Int J Psychiatry Med 23:308–312

    Article  Google Scholar 

  • Hack M, Youngstrom EA, Cartar L et al (2004) Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 114:932–940

    Article  PubMed  Google Scholar 

  • Hinton VJ, Nereo NE, Fee RJ, Cyrulnik SE (2006) Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr 27:470–476

    Article  PubMed  Google Scholar 

  • Hoffman B, Garcia de Lorenzo A, Mehta A et al (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet 42:247–252

    Article  Google Scholar 

  • Hoffman B, Beck M, Sunder Plassman G et al (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy—a retrospective analysis from the Fabry outcome survey. Clin J Pain 23:535–542

    Article  Google Scholar 

  • Howe GW, Feinstein C, Reiss D, Molock S, Berger K (1993) Adolescent adjustment to chronic physical disorders: I. Comparing neurological and non-neurological conditions. J Child Psychol Psychiatry 34:1153–1171

    Article  PubMed  CAS  Google Scholar 

  • Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ (2002) The heart in Anderson Fabry disease. Z Kardiol 91:786–795

    Article  PubMed  CAS  Google Scholar 

  • Katon W, Russo J, Lin EH et al (2009) Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 50:570–579

    Google Scholar 

  • Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont) 6:38–51

    Google Scholar 

  • Klonsky ED (2002) Valid inferences from invalid tests? Am Psychol 57:990

    Article  PubMed  Google Scholar 

  • MacDermot K, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769–775

    Article  PubMed  CAS  Google Scholar 

  • Miners A, Holmes A, Sherr L et al (2002) Assessment of health-related quality-of-life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127–133

    Article  PubMed  CAS  Google Scholar 

  • Muller M, Muller KM, Dascalescu A et al (2005) Psychiatric and neuropsychological signs and symptoms in patients with Fabry disease: literature review. Fortschr Neurol Psychiatr 73:687–693

    Article  PubMed  CAS  Google Scholar 

  • Mureau MAM, Slijper FME, Slob AK, Verhulst FC (1997) Psychosocial functioning of children, adolescents, and adults following hypospadias surgery: a comparative study. J Pediatr Psychol 22:371–387

    Article  PubMed  CAS  Google Scholar 

  • RADAR (2009) The Fabry Registry Aggregate Data Annual Report (RADAR). Fabry registry. Genzyme Corporation, Boston, MA

    Google Scholar 

  • Roza SJ, Hofstra MB, van der Ende J, Verhulst FC (2003) Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood. Am J Psychiatry 160:2116–2121

    Article  PubMed  Google Scholar 

  • Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201

    Article  PubMed  Google Scholar 

  • Sbarra DA, Rimm-Kaufman SE, Pianta RC (2002) The behavioral and emotional correlates of epilepsy in adolescence: a 7-year follow-up. Epilepsy Behav 3:358–367

    Article  PubMed  Google Scholar 

  • Schiffmann R, Scott LJ (2002) Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl 91:48–52

    Article  PubMed  CAS  Google Scholar 

  • Stavro GM, Ettenhofer ML, Nigg JT (2007) Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc 13:324–334

    Article  PubMed  Google Scholar 

  • Street N, Yi MS, Bailey LA, Hopkin RJ (2006) Comparison of health related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med 8:346–353

    Article  PubMed  Google Scholar 

  • Todd RD, Huang H, Todorov AA, Neuman RJ, Reiersen AM, Henderson CA, Reich WC (2008) Predictors of stability of attention-deficit/hyperactivity disorder subtypes from childhood to young adulthood. J Am Acad Child Adolesc Psychiatry 47:76–85

    Article  PubMed  Google Scholar 

  • van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2007) Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study. Psychol Med 37:1635–1644

    PubMed  Google Scholar 

  • van Pareren YK, Duivenvoorden HJ, Slijper FME et al (2005) Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm Res 63:238–244

    Google Scholar 

  • van Rijen EHM, Utens EMWJ, Roos-Hesselink JW et al (2004) Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 25:1605–1613

    Article  PubMed  Google Scholar 

  • Väistö T, Aronen ET, Simola P, Ashorn M, Kolho KL (2009) Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis 16:27–35

    Google Scholar 

  • Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34–45

    Google Scholar 

  • West M, LeMoine K (2007) Withdrawal of enzyme replacement therapy in Fabry disease: indirect evidence of treatment benefit? Mol Genet Metab 92:32

    Article  Google Scholar 

  • Whybra C, Kampmann C, Krummenauer F et al (2004) The Mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299–307

    Article  PubMed  CAS  Google Scholar 

  • Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112–128

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Andrea Knezevic in the Emory University Department of Biostatistics in the Rollins School of Public Health for her assistance with statistical analysis. They also thank all the individuals who participated in this study for their candor on a difficult and personal subject.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dawn Alyssia Laney.

Additional information

Communicated by: Alberto B. Burlina

References to electronic databases: OMIM: Fabry disease: OMIM 301500, α-galactosidase A, EC 3.2.1.22

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laney, D.A., Gruskin, D.J., Fernhoff, P.M. et al. Social-adaptive and psychological functioning of patients affected by Fabry disease. J Inherit Metab Dis 33 (Suppl 3), 73–81 (2010). https://doi.org/10.1007/s10545-009-9025-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-009-9025-6

Keywords

Navigation